Comparison

Insulin peglispro European Partner

Item no. HY-P4062-1ea
Manufacturer MedChem Express
CASRN 1200440-65-8
Amount 1 ea
Category
Type Inhibitor
Specific against other
Formula C370H566N104O110S4
Citations [1]Richard A Byrd, et al. Chronic Toxicology Studies of Basal Insulin Peglispro in Rats and Dogs: A Novel, PEGylated Insulin Lispro Analog with a Prolonged Duration of Action. Toxicol Pathol. 2017 Apr;45(3):402-415. 
Smiles [Chain1:FVNQHLCGSHLVEALYLVCGERGFFYTKPT<br />Chain2:GIVEQCCTSICSLYQLENYCN<br />(Disulfide chain 1 cys7-chain 2 cys7, Disulfide chain 1 cys19-chain 2 cys20, Disulfide chain 2 cys6-cys11)]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BIL
Shipping condition Room temperature
Available
Manufacturer - Type
Peptides
Manufacturer - Applications
Metabolism-sugar/lipid metabolism
Manufacturer - Targets
Insulin Receptor
Shipping Temperature
Room Temperature
Product Description
Insulin peglispro (BIL) is a basal insulin with a flat, prolonged activity profile. Insulin peglispro can exhibit better glycaemic control compared to conventional insulins[1].
Manufacturer - Research Area
Metabolic Disease
Solubility
10 mM in DMSO
Manufacturer - Pathway
Protein Tyrosine Kinase/RTK
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close